Ligand-induced changes in estrogen receptor conformation as measured by site-directed spin labeling.
D019943:Amino Acid Substitution / Q000235:genetics; D001665:Binding Sites; D003497:Cyclic N-Oxides / Q000378:metabolism; D003545:Cysteine / Q000235:genetics / Q000378:metabolism; D004578:Electron Spin Resonance Spectroscopy; D004958:Estradiol / Q000031:analogs & derivatives* / Q000737:chemistry; D004964:Estriol / Q000737:chemistry; D047628:Estrogen Receptor alpha; D004970:Estrone / Q000737:chemistry; D006801:Humans; D016018:Least-Squares Analysis; D008024:Ligands; D016014:Linear Models; D016297:Mutagenesis, Site-Directed; D011487:Protein Conformation; D017434:Protein Structure, Tertiary / Q000235:genetics; D011960:Receptors, Estrogen / Q000737:chemistry* / Q000235:genetics* / Q000378:metabolism; D021241:Spectrometry, Mass, Electrospray Ionization; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013113:Spin Labels
D003497:Cyclic N-Oxides; D047628:Estrogen Receptor alpha; D008024:Ligands; D011960:Receptors, Estrogen; D013113:Spin Labels; C029910:3-(2-iodoacetamido)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl; D004970:Estrone; D004958:Estradiol; C038957:11-beta-chloromethyl-estradiol; D004964:Estriol; D003545:Cysteine